Chronic Leukemia Journal Articles

• Risks of Second Non-Breast Primaries Following Breast Cancer A better understanding of the potential risks of developing second primary malignancies among survivors of breast cancer could lead to better prevention and management strategies for these patients.
  Breast Cancer Research, May 05, 2023
• Improving the Laboratory Evaluation of Monoclonal Gammopathies The authors developed a targeted clinical decision support alert to address oversights in ordering practices for the initial laboratory evaluation of monoclonal gammopathies.
  American Journal of Clinical Pathology, February 21, 2023
• How I Diagnose Mature T-Cell Proliferations by Flow Cytometry Peripheral T-cell neoplasms can be diagnostically challenging. Using two illustrative cases, this paper reviews the application of flow cytometry to the interpretation of mature T-cell proliferations.
  American Journal of Clinical Pathology, October 25, 2022
• Ibrutinib Plus Venetoclax for First-Line Treatment of CLL Primary analysis results from the CAPTIVATE study demonstrate the potential of this combination treatment as a fixed-duration, first-line therapeutic option for chronic lymphocytic leukemia.
  Journal of Clinical Oncology, September 08, 2022
• Next-generation Antibody-based Therapies in Neurology This article reviews the biology of antibody-based therapeutics, summarizing promising new developments in their potential application in a variety of neurological diseases.
  Brain, July 08, 2022
• COVID-19 and Immune-Mediated RBC Destruction Cases of autoimmune hemolytic anemia have been reported with COVID-19. This article summarizes the epidemiologic, clinical, and laboratory characteristics of patients with COVID-19-associated AIHA.
  American Journal of Clinical Pathology, June 30, 2022
• Safety of IV Golimumab in RA, PsA, and AS A pooled analysis of data from three trials provides insight into the safety profile of IV golimumab for the treatment of these rheumatologic conditions.
  Arthritis Research & Therapy, May 18, 2022
• Cryotherapy for Cutaneous Kaposi Sarcoma With B-Cell CLL This report describes the treatment of cutaneous Kaposi sarcoma in a patient with B-cell CLL using cryotherapy.
  Wounds, March 18, 2022
• The BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients Is the SARS-CoV-2 BNT162b2 vaccine safe and effective in cancer patients receiving active treatment?
  Journal of the National Cancer Institute, March 09, 2022
• Malignancy Risk in Patients With Secukinumab-treated Psoriasis Does treatment with secukinumab increase the risk of malignancy in patients being treated for psoriasis, psoriatic arthritis, or ankylosing spondylitis?
  The British Journal of Dermatology, December 07, 2021
• SARS-CoV-2 Variants in Patient Given Antibody Monotherapy This case highlights the need for genomic surveillance for variants among COVID-19 patients who receive antibody monotherapy treatment.
  Emerging Infectious Diseases, November 11, 2021
• Pulmonary Pathology of COVID-19 Following Severe Disease This retrospective case series details histologic lung pathology in the aftermath of severe COVID-19 managed with prolonged mechanical ventilation.
  American Journal of Clinical Pathology, April 12, 2021
• Autophagy in Hematological Malignancies This review examines the autophagy pathway and its role in the development of hematological malignancies, with a focus on myeloid and lymphoid leukemia and lymphoma.
  Laboratory Medicine, February 03, 2021
• Cardio-Oncology: Ibrutinib Effect Reveals Insights Into AF This report advances our understanding of the pathophysiology of AF related to ibrutinib, a BTK inhibitor used in the treatment of various lymphoid malignancies.
  Circulation, February 02, 2021
• Combination Obinutuzumab, Ibrutinib, and Venetoclax in CLL This combination regimen may be a safe and effective option for treatment-naive and relapsed or refractory CLL patients.
  Journal of Clinical Oncology, December 29, 2020
• Acalabrutinib vs Idelalisib-R or Bendamustine-R in CLL How do these treatment regimens for relapsed/refractory chronic lymphocytic leukemia compare in terms of safety and progression-free survival?
  Journal of Clinical Oncology, December 15, 2020
• Cladribine With Concurrent or Delayed Rituximab in HCL Could the addition of rituximab to cladribine treatment help clear minimal residual disease in patients with hairy cell leukemia?
  Journal of Clinical Oncology, August 03, 2020
• Rapid Cognitive Decline in a Patient With CLL This 68-year-old patient being treated with ofatumumab for chronic lymphocytic leukemia presented with progressive cognitive decline and neurological dysfunction. What was the cause?
  Journal of Medical Case Reports, May 05, 2020
• HBV and HCV Infection and Risk of Hematological Malignancies This article reviews the oncogenic mechanisms of HCV and HBV, and examines the impact and the safety of antiviral treatment in patients with hematological malignancies.
  Journal of Viral Hepatitis, January 06, 2020
• Limited Tissue Biopsies and Hematolymphoid Neoplasms This study examines the applicability of fine-needle aspiration/needle core biopsy for evaluating hematolymphoid lesions.
  American Journal of Clinical Pathology, December 10, 2019